Final answer:
Patients with Acute Myeloid Leukemia typically have a lower platelet count, which causes increased bleeding and bruising due to the insufficient number of platelets needed to form blood clots.
Step-by-step explanation:
Acute Myeloid Leukemia patients have a decreased platelet count, leading to longer clotting times and increased bleeding and bruising.
Patients with Acute Myeloid Leukemia (AML) often suffer from thrombocytopenia, a condition characterized by a lower than normal number of platelets in the blood. Platelets are crucial for blood clotting, and their deficiency can lead to an increased risk of excessive bleeding, even from minor injuries.
Acute Myeloid Leukemia patients have a low platelet count, leading to longer clotting times and excessive bleeding and bruising. When the number of platelets decreases, it can result in difficulties in forming clots and an increased risk of bleeding. This can manifest as prolonged clotting times and the development of bleeding and bruising even from minor injuries or trauma.